29
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Increased plasma hyaluronan in severe pre-eclampsia and eclampsia

Pages 131-137 | Published online: 08 Jul 2009

REFERENCES

  • Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom 1991–1993. London: HMSO, 1996.
  • Mushambi MC, Halligan AW, Williamson K. Recent development in the pathophysiology and management of pre-eclampsia. Br J Anaesth 1996; 76: 133–48.
  • Linton DM, Anthony J. Critical care management of severe pre-eclampsia. Intensive Care Med 1997; 23: 248–55.
  • Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000— 6.
  • Redman CWG, Roberts JM. Management of pre-eclampsia. Lancet 1993; 341: 1451–4.
  • Smedsröd B, Pertoft H, Gustafson S, Laurent TC. Scavenger functions of the liver endothelial cell. Biochem J 1990; 266: 313–27.
  • Laurent TC, Laurent UB, Fraser JR. Serum hyaluronan as a disease marker. Ann Med 1996; 28: 241–53.
  • Engstrom-Laurent A. Hyaluronan in joint disease. J Intern Med 1997; 242: 57–60.
  • Engstrom-Laurent A, Loof L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5: 638–42.
  • Lindqvist U. Is serum hyaluronan a helpful tool in the management of patients with liver diseases? J Intern Med 1997; 242: 67–71.
  • Berg S, Brodin B, Hesselvik F, Laurent TC, Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest 1988; 48: 727— 32.
  • Berg S, Jansson I, Hesselvik JF, Laurent TC, Lennquist S, Walther S. Hyaluronan: Relationship to hemodynamics and survival in porcine injury and sepsis. Crit Care Med 1992; 20: 1315–21.
  • Berg S. Hyaluronan turnover in relation to infection and sepsis. J Intern Med 1997; 242: 73–7.
  • Brandt R, Hedlof E, Asman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluro-nan. Acta Otolaryngol (Stockh) 1987; Suppl. 442: 31–5.
  • Osmers RG, Schutz E, Diedrich F, Wehry B, Krauss T, Oellerich M, et al. Increased serum levels of hyaluronic acid in pregnancies compli-cated by preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Obstet Gynecol 1998; 178: 341–5.
  • Lindqvist U, Laurent TC. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 1992; 52: 613–21.
  • Kobayashi H, Sun G, Tanaka Y, Kondo T, Terao T. Serum hyaluronic acid levels during pregnancy and labor. Obstet Gynecol 1999; 93: 480–4.
  • Dahl L, Hopwood JJ, Laurent UBG, Lilja K, Tengblad A. The concentration of hyaluronate in amniotic fluid. Biochem Med 1983; 30: 280–3.
  • Dahl LB, Dahl IMS, Borresen AL. The molecular weight of sodium hyaluronate in amniotic fluid. Biochem Med Metab Biol 1986; 35: 219–26.
  • Wasserman L, Shlesinger H, Abramovici A, Goldman JA, Allalouf D. Glycosaminoglycan patterns in diabetic and toxemic term placentas. Am J Obstet Gynecol 1980; 138: 769–73.
  • Toole BP. Hyaluronan in morphogenesis. J Intern Med 1997; 242: 35–40.
  • Rajabi MR, Quillen EW, Nuwayhid BS, Brandt R, Poole AR. Circulating hyaluronic acid in nonpregnant, pregnant, and postpartum guinea pigs: elevated levels observed at parturition. Am J Obstet Gynecol 1992; 166: 242–6.
  • Lebel L, Gabrielsson J, Laurent TC, Gerdin B. Kinetics of circulating hyaluronan in humans. Eur J Clin Invest 1994; 24: 621–6.
  • Lindqvist U, Groth T, Lebel L. Evaluation of various models of hyaluronan kinetics for assessment of liver function. Scand J Clin Lab Invest 1997; 57: 49–58.
  • Saftlas AE, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States 1979-1986. Am J Obstet Gynecol 1990; 163: 460–5.
  • Sibai BM, Frangieh AY. Management of severe preeclampsia. Curr Opin Obstet Gynecol 1996; 8: 110–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.